Mirena Efficiency and Tolerability During the First Year of Use

NCT00696202 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 199

Last updated 2014-12-31

No results posted yet for this study

Summary

In this trial the efficacy and safety of Mirena was investigated during the first year of use

Conditions

  • Medicated Intrauterine Devices
  • Contraception

Interventions

DRUG

Mirena (BAY86-5028)

Intrauterine levonorgestrel containing device (market product)

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
39 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-09-30
Completion
2005-03-31

Countries

  • France

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00696202 on ClinicalTrials.gov